Literature DB >> 22005689

Intra-arterial chemotherapy for malignant gliomas: a critical analysis.

J-K Burkhardt1, H A Riina, B J Shin, J A Moliterno, C P Hofstetter, J A Boockvar.   

Abstract

Intra-arterial (IA) chemotherapy for malignant gliomas including glioblastoma multiforme was initiated decades ago, with many preclinical and clinical studies having been performed since then. Although novel endovascular devices and techniques such as microcatheter or balloon assistance have been introduced into clinical practice, the question remains whether IA therapy is safe and superior to other drug delivery modalities such as intravenous (IV) or oral treatment regimens. This review focuses on IA delivery and surveys the available literature to assess the advantages and disadvantages of IA chemotherapy for treatment of malignant gliomas. In addition, we introduce our hypothesis of using IA delivery to selectively target cancer stem cells residing in the perivascular stem cell niche.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22005689      PMCID： PMC3396041          DOI： 10.1177/159101991101700302

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


  80 in total

1.  INTRA-ARTERIAL VINCRISTINE THERAPY OF PRIMARY GLIOMAS.

Authors:  G OWENS; R JAVID; L BELMUSTO; M BENDER; M BLAU
Journal:  Cancer       Date:  1965-06       Impact factor: 6.860

2.  Absence of thymus in a mouse mutant.

Authors:  E M Pantelouris
Journal:  Nature       Date:  1968-01-27       Impact factor: 49.962

3.  Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial.

Authors:  L Recht; R J Fram; G Strauss; T J Fitzgerald; M Liepman; R Lew; S Kadish; D Sherman; J Wilson; J Greenberger
Journal:  Am J Clin Oncol       Date:  1990-04       Impact factor: 2.339

Review 4.  Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.

Authors:  Aalya Fatoo; Michael J Nanaszko; Baxter B Allen; Christina L Mok; Elena N Bukanova; Robel Beyene; Jennifer A Moliterno; John A Boockvar
Journal:  J Neurooncol       Date:  2010-09-18       Impact factor: 4.130

5.  Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.

Authors:  A I Qureshi; M F Suri; J Khan; M Sharma; K Olson; L R Guterman; L N Hopkins
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

6.  Penetration of intra-arterially administered vincristine in experimental brain tumor.

Authors:  Frances M Boyle; Susan L Eller; Stuart A Grossman
Journal:  Neuro Oncol       Date:  2004-10       Impact factor: 12.300

7.  Blood-brain barrier disruption in immature Fischer 344 rats.

Authors:  D E Bullard; D D Bigner
Journal:  J Neurosurg       Date:  1984-04       Impact factor: 5.115

8.  Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.

Authors:  H Safdari; B Mompeon; J B Dubois; C Gros
Journal:  Surg Neurol       Date:  1985-11

Review 9.  Pseudoprogression and pseudoresponse in the treatment of gliomas.

Authors:  Dieta Brandsma; Martin J van den Bent
Journal:  Curr Opin Neurol       Date:  2009-12       Impact factor: 5.710

10.  Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.

Authors:  L G Feun; Y Y Lee; W K Yung; C Charnsangavej; N Savaraj; R A Tang; S Wallace
Journal:  Cancer Drug Deliv       Date:  1986
View more
  13 in total

1.  Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications.

Authors:  Xiao-Hong Shu; Li-Li Wang; Hong Li; Xue Song; Shun Shi; Jia-Yao Gu; Mo-Li Wu; Xiao-Yan Chen; Qing-You Kong; Jia Liu
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

2.  A Distinct Advantage to Intraarterial Delivery of 89Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood-Brain Barrier.

Authors:  Wojciech G Lesniak; Chengyan Chu; Anna Jablonska; Yong Du; Martin G Pomper; Piotr Walczak; Miroslaw Janowski
Journal:  J Nucl Med       Date:  2018-10-12       Impact factor: 10.057

3.  A murine model of targeted infusion for intracranial tumors.

Authors:  Minhyung Kim; Tara A Barone; Natalia Fedtsova; Anatoli Gleiberman; Chandler D Wilfong; Julie A Alosi; Robert J Plunkett; Andrei Gudkov; Joseph J Skitzki
Journal:  J Neurooncol       Date:  2015-09-16       Impact factor: 4.130

4.  Short-term clinico-radiographic response to super-selective intra-arterial cerebral infusion of Bevacizumab for the treatment of vestibular schwannomas in Neurofibromatosis type 2.

Authors:  H A Riina; J-K Burkhardt; A Santillan; L Bassani; A Patsalides; J A Boockvar
Journal:  Interv Neuroradiol       Date:  2012-06-04       Impact factor: 1.610

Review 5.  Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.

Authors:  Hajime Takase; Reo Tanoshima; Navneet Singla; Yoshihiko Nakamura; Tetsuya Yamamoto
Journal:  Neurosurg Rev       Date:  2021-10-20       Impact factor: 3.042

6.  The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy.

Authors:  Liping Yang; Jingxiang Zhao; Guihong Zhou; Yunfang Wang; Lusi Li; Hongfeng Yuan; Xue Nan; Lidong Guan; Xuetao Pei
Journal:  Neural Regen Res       Date:  2012-06-25       Impact factor: 5.135

Review 7.  Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.

Authors:  T Burt; R J Noveck; D B MacLeod; A T Layton; M Rowland; G Lappin
Journal:  Clin Transl Sci       Date:  2017-04-18       Impact factor: 4.689

8.  Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.

Authors:  Lawrence Kleinberg
Journal:  Core Evid       Date:  2012-10-26

9.  Interval between intra-arterial infusion chemotherapy and surgery for locally advanced oral squamous cell carcinoma: impacts on effectiveness of chemotherapy and on overall survival.

Authors:  Chih-Fung Wu; Chien-Hsing Lee; Edward Hsi; Chung-Ho Chen; Jen-Yang Tang
Journal:  ScientificWorldJournal       Date:  2014-05-18

10.  Low-dose bevacizumab induces radiographic regression of vestibular schwannomas in neurofibromatosis type 2: A case report and literature review.

Authors:  Pengfei Liu; Qingyu Yao; N A Li; Yongliang Liu; Yuguo Wang; Meng Li; Zefu Li; Jianmin Li; Gang Li
Journal:  Oncol Lett       Date:  2016-03-17       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.